Julie Zhen Qin Wu

Array ( [id] => 7488865 [patent_doc_number] => 20110236979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'Apparatus for Generating Electrical Pulses and Methods of Using Same' [patent_app_type] => utility [patent_app_number] => 13/073785 [patent_app_country] => US [patent_app_date] => 2011-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 13568 [patent_no_of_claims] => 132 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236979.pdf [firstpage_image] =>[orig_patent_app_number] => 13073785 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8791653 [patent_doc_number] => 20130108622 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-02 [patent_title] => 'DISULFIDE STABILIZED ANTIBODIES AND FRAGMENTS THEREOF' [patent_app_type] => utility [patent_app_number] => 13/637209 [patent_app_country] => US [patent_app_date] => 2011-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9719 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637209 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8990354 [patent_doc_number] => 20130217635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'NOVEL USE OF ERYTHROID DIFFERENTIATION REGULATOR 1 AS AN AGENT FOR TREATING CANCER' [patent_app_type] => utility [patent_app_number] => 13/637155 [patent_app_country] => US [patent_app_date] => 2011-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9606 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13637155 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10115786 [patent_doc_number] => 09150656 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/581340 [patent_app_country] => US [patent_app_date] => 2011-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 85 [patent_no_of_words] => 52283 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13581340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11561718 [patent_doc_number] => 09624290 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-18 [patent_title] => 'Lowered affinity antibodies and methods of making the same' [patent_app_type] => utility [patent_app_number] => 13/575219 [patent_app_country] => US [patent_app_date] => 2011-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13275 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 159 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13575219 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6174332 [patent_doc_number] => 20110177082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-21 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF OVARIAN CANCER' [patent_app_type] => utility [patent_app_number] => 13/009413 [patent_app_country] => US [patent_app_date] => 2011-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 101 [patent_figures_cnt] => 101 [patent_no_of_words] => 51903 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13009413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477144 [patent_doc_number] => 20120276552 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'SERUM SPLA2-IIA AS DIAGNOSIS MARKER FOR PROSTATE AND LUNG CANCER' [patent_app_type] => utility [patent_app_number] => 13/520586 [patent_app_country] => US [patent_app_date] => 2011-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 7230 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13520586 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8607139 [patent_doc_number] => 20130012451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITING MMP-9-MEDIATED CELL MIGRATION' [patent_app_type] => utility [patent_app_number] => 13/518289 [patent_app_country] => US [patent_app_date] => 2010-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22117 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13518289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8670668 [patent_doc_number] => 20130045206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-21 [patent_title] => 'ANTIBODIES DIRECTED AGAINST THE TRANSFERRIN RECEPTOR AND USES THEREOF FOR IMMUNOTHERAPY OF IRON-DEPENDENT TUMOURS' [patent_app_type] => utility [patent_app_number] => 13/515551 [patent_app_country] => US [patent_app_date] => 2010-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 11902 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13515551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8637560 [patent_doc_number] => 20130029363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'METHOD FOR DIAGNOSING MALIGNANT TUMOR' [patent_app_type] => utility [patent_app_number] => 13/512903 [patent_app_country] => US [patent_app_date] => 2010-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6269 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9003077 [patent_doc_number] => 20130224202 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-29 [patent_title] => 'SINGLE-CHAIN VARIABLE FRAGMENT ANTI-CD133 ANTIBODIES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/699944 [patent_app_country] => US [patent_app_date] => 2010-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 26413 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13699944 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8476692 [patent_doc_number] => 20120276099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'MONOSPECIFIC POLYPEPTIDE REAGENTS' [patent_app_type] => utility [patent_app_number] => 13/512206 [patent_app_country] => US [patent_app_date] => 2010-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 14644 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13512206 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8502081 [patent_doc_number] => 20120301489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-29 [patent_title] => 'Jagged-Binding Agents and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/510666 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 36595 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477918 [patent_doc_number] => 20120277326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'BIOMARKERS OF CANCER' [patent_app_type] => utility [patent_app_number] => 13/510849 [patent_app_country] => US [patent_app_date] => 2010-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9720 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13510849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11408980 [patent_doc_number] => 09556272 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-31 [patent_title] => 'Anti-TEM1 antibodies and uses thereof' [patent_app_type] => utility [patent_app_number] => 13/508925 [patent_app_country] => US [patent_app_date] => 2010-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 29977 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8509070 [patent_doc_number] => 20120308478 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-12-06 [patent_title] => 'ANTIBODIES SPECIFIC FOR CLAUDIN 6 (CLDN6)' [patent_app_type] => utility [patent_app_number] => 13/503461 [patent_app_country] => US [patent_app_date] => 2010-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 41469 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503461 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8465071 [patent_doc_number] => 20120270239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-10-25 [patent_title] => 'MELANOMA PROGNOSTIC MODEL USING TISSUE MICROARRAYS AND GENETIC ALGORITHMS' [patent_app_type] => utility [patent_app_number] => 13/505240 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20136 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13505240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9823103 [patent_doc_number] => 08932588 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-01-13 [patent_title] => 'Treatment of cancer involving mutated KRAS or BRAF genes' [patent_app_type] => utility [patent_app_number] => 13/508207 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 10386 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 94 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13508207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9983113 [patent_doc_number] => 09028817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Stable anti-TNFR1 polypeptides, antibody variable domains and antagonists' [patent_app_type] => utility [patent_app_number] => 13/504525 [patent_app_country] => US [patent_app_date] => 2010-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 29726 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13504525 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8477147 [patent_doc_number] => 20120276555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-01 [patent_title] => 'Method of Using Non-Rare Cells to Detect Rare Cells' [patent_app_type] => utility [patent_app_number] => 13/503014 [patent_app_country] => US [patent_app_date] => 2010-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15083 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13503014 [rel_patent_id] =>[rel_patent_doc_number] =>)